MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.gie.2024.02.012

Медицинская библиотека · Gastrointestinal endoscopy · 2024

EUS-guided hepaticogastrostomy versus EUS-guided hepaticogastrostomy with antegrade stent placement in patients with unresectable malignant distal biliary obstruction: a propensity score-matched case-control study.

Ishiwatari Hirotoshi, Ogura Takeshi, Hijioka Susumu, Iwashita Takuji, Matsubara Saburo, Ishikawa Kazuma, Niiya Fumitaka, Sato Junya, Okuda Atsushi, Ueno Saori, Nagashio Yoshikuni, Maruki Yuta, Uemura Shinya, Notsu Akifumi

СтатьяСравнительное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: EUS-guided hepaticogastrostomy (EUS-HGS) is a rescue procedure when ERCP fails. Peritonitis and recurrent biliary obstruction (RBO) are adverse events (AEs) associated with EUS-HGS. Antegrade stent placement across a malignant distal biliary obstruction (DBO) followed by EUS-HGS (EUS-HGAS) creates 2 biliary drainage routes, potentially reducing peritonitis and prolonging time to RBO (TRBO). We compared the outcomes of the 2 techniques.

METHODS

Data of consecutive patients with malignant DBO who underwent attempted EUS-HGS or EUS-HGAS across 5 institutions from January 2014 to December 2020 were retrospectively analyzed. A matched cohort of patients was obtained using 1-to-1 propensity score matching. The primary outcome was TRBO, and secondary outcomes were AEs except for RBO and overall survival.

RESULTS

Among 360 patients, 283 (176 and 107 in the HGS and HGAS groups, respectively) were eligible. The matched cohorts included 81 patients in each group. AEs developed in 10 (12.3%) and 15 (18.5%) patients (P = .38) in the HGS and HGAS groups, respectively. RBO occurred in 18 and 2 patients in the HGS and HGAS groups, respectively (P < .001). TRBO was significantly longer in the HGAS group (median, 194 days vs 716 days; hazard ratio, .050; 95% confidence interval, .0066-.37; P < .01). However, no significant differences occurred in overall survival between the groups (median, 97 days vs 112 days; hazard ratio, .97; 95% confidence interval, .66-1.4; P = .88).

CONCLUSIONS

EUS-HGAS extended TRBO compared with EUS-HGS, whereas AEs, except for RBO and overall survival, did not differ. The longer TRBO of EUS-HGAS could benefit patients with longer life expectancy.

Для цитирования: Ishiwatari Hirotoshi, Ogura Takeshi, Hijioka Susumu, Iwashita Takuji, Matsubara Saburo, Ishikawa Kazuma, Niiya Fumitaka, Sato Junya, Okuda Atsushi, Ueno Saori, Nagashio Yoshikuni, Maruki Yuta, Uemura Shinya, Notsu Akifumi. EUS-guided hepaticogastrostomy versus EUS-guided hepaticogastrostomy with antegrade stent placement in patients with unresectable malignant distal biliary obstruction: a propensity score-matched case-control study.. Gastrointestinal endoscopy. 2024. DOI: 10.1016/j.gie.2024.02.012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.